Sarepta Therapeutic (SRPT) PT Cut to $7 at Jefferies Following Negative AdCom
Tweet Send to a Friend
Jefferies analyst Gena Wang lowered her price target on Hold-rated Sarepta Therapeutic (NASDAQ: SRPT) to $7.00 (from $14.00) following a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
